Global law firm White & Case LLP has advised Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, on its participation in a US$116 million Series B financing of Entrada Therapeutics Inc., a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics.
The financing closed on March 31, 2021.
The White & Case team which advised on the transaction was led by partner Gary Silverman (Chicago) and included partners Andrew Kreisberg (Los Angeles) and Anita Varma (Boston), counsel Kenneth Barr (New York), and associates David Smith (Frankfurt), Matthew Sieben (Chicago), Ilan Har-El (New York), Ajita Shukla (Washington, DC), Yang Xu (Silicon Valley) and Anthony Veveakis (New York).
Press contact
For more information please speak to your local media contact.
